180 related articles for article (PubMed ID: 24086340)
1. Association of p62/SQSTM1 excess and oral carcinogenesis.
Inui T; Chano T; Takikita-Suzuki M; Nishikawa M; Yamamoto G; Okabe H
PLoS One; 2013; 8(9):e74398. PubMed ID: 24086340
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of p62/SQSTM1 subcellular localization and LC3B in oral squamous cell carcinoma.
Liu JL; Chen FF; Lung J; Lo CH; Lee FH; Lu YC; Hung CH
Br J Cancer; 2014 Aug; 111(5):944-54. PubMed ID: 24983366
[TBL] [Abstract][Full Text] [Related]
3. p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors.
Kuo WL; Sharifi MN; Lingen MW; Ahmed O; Liu J; Nagilla M; Macleod KF; Cohen EE
PLoS One; 2014; 9(3):e90171. PubMed ID: 24599075
[TBL] [Abstract][Full Text] [Related]
4. Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma.
Sakakura K; Takahashi H; Kaira K; Toyoda M; Oyama T; Chikamatsu K
Cancer Sci; 2015 Jan; 106(1):1-8. PubMed ID: 25338734
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma.
Inoue D; Suzuki T; Mitsuishi Y; Miki Y; Suzuki S; Sugawara S; Watanabe M; Sakurada A; Endo C; Uruno A; Sasano H; Nakagawa T; Satoh K; Tanaka N; Kubo H; Motohashi H; Yamamoto M
Cancer Sci; 2012 Apr; 103(4):760-6. PubMed ID: 22320446
[TBL] [Abstract][Full Text] [Related]
6. 13-Acetoxysarcocrassolide Exhibits Cytotoxic Activity Against Oral Cancer Cells Through the Interruption of the Keap1/Nrf2/p62/SQSTM1 Pathway: The Need to Move Beyond Classical Concepts.
Liu YC; Peng BR; Hsu KC; El-Shazly M; Shih SP; Lin TE; Kuo FW; Chou YC; Lin HY; Lu MC
Mar Drugs; 2020 Jul; 18(8):. PubMed ID: 32718084
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous activation of impaired autophagy and the mammalian target of rapamycin pathway in oral squamous cell carcinoma.
Yin X; Hu L; Feng X; Wang H; Zhang C; Wang H; Wang S
J Oral Pathol Med; 2019 Sep; 48(8):705-711. PubMed ID: 31132188
[TBL] [Abstract][Full Text] [Related]
8. p62/SQSTM1 is involved in cisplatin resistance in human ovarian cancer cells via the Keap1-Nrf2-ARE system.
Xia M; Yu H; Gu S; Xu Y; Su J; Li H; Kang J; Cui M
Int J Oncol; 2014 Dec; 45(6):2341-8. PubMed ID: 25269472
[TBL] [Abstract][Full Text] [Related]
9. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription.
Jain A; Lamark T; Sjøttem E; Larsen KB; Awuh JA; Øvervatn A; McMahon M; Hayes JD; Johansen T
J Biol Chem; 2010 Jul; 285(29):22576-91. PubMed ID: 20452972
[TBL] [Abstract][Full Text] [Related]
10. TAK1 Regulates the Nrf2 Antioxidant System Through Modulating p62/SQSTM1.
Hashimoto K; Simmons AN; Kajino-Sakamoto R; Tsuji Y; Ninomiya-Tsuji J
Antioxid Redox Signal; 2016 Dec; 25(17):953-964. PubMed ID: 27245349
[TBL] [Abstract][Full Text] [Related]
11. Dissection of the role of p62/Sqstm1 in activation of Nrf2 during xenophagy.
Ishimura R; Tanaka K; Komatsu M
FEBS Lett; 2014 Mar; 588(5):822-8. PubMed ID: 24492006
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1.
Gjyshi O; Flaherty S; Veettil MV; Johnson KE; Chandran B; Bottero V
J Virol; 2015 Feb; 89(4):2268-86. PubMed ID: 25505069
[TBL] [Abstract][Full Text] [Related]
13. Negative Regulation of the Keap1-Nrf2 Pathway by a p62/Sqstm1 Splicing Variant.
Kageyama S; Saito T; Obata M; Koide RH; Ichimura Y; Komatsu M
Mol Cell Biol; 2018 Apr; 38(7):. PubMed ID: 29339380
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of GSH synthesis to prevent oxidative stress-induced apoptosis by hydroxytyrosol in human retinal pigment epithelial cells: activation of Nrf2 and JNK-p62/SQSTM1 pathways.
Zou X; Feng Z; Li Y; Wang Y; Wertz K; Weber P; Fu Y; Liu J
J Nutr Biochem; 2012 Aug; 23(8):994-1006. PubMed ID: 21937211
[TBL] [Abstract][Full Text] [Related]
15. Autophagy activation clears ELAVL1/HuR-mediated accumulation of SQSTM1/p62 during proteasomal inhibition in human retinal pigment epithelial cells.
Viiri J; Amadio M; Marchesi N; Hyttinen JM; Kivinen N; Sironen R; Rilla K; Akhtar S; Provenzani A; D'Agostino VG; Govoni S; Pascale A; Agostini H; Petrovski G; Salminen A; Kaarniranta K
PLoS One; 2013; 8(7):e69563. PubMed ID: 23922739
[TBL] [Abstract][Full Text] [Related]
16. SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity.
Lee DH; Park JS; Lee YS; Han J; Lee DK; Kwon SW; Han DH; Lee YH; Bae SH
Autophagy; 2020 Nov; 16(11):1949-1973. PubMed ID: 31913745
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic Drugs Activate KSHV Lytic Cycle in Latently Infected PEL Cells by Inducing a Moderate ROS Increase Controlled by HSF1, NRF2 and p62/SQSTM1.
Granato M; Gilardini Montani MS; Angiolillo C; D'Orazi G; Faggioni A; Cirone M
Viruses; 2018 Dec; 11(1):. PubMed ID: 30586869
[TBL] [Abstract][Full Text] [Related]
18. New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone.
Rea SL; Walsh JP; Layfield R; Ratajczak T; Xu J
Endocr Rev; 2013 Aug; 34(4):501-24. PubMed ID: 23612225
[TBL] [Abstract][Full Text] [Related]
19. Sequestosome1/p62: a regulator of redox-sensitive voltage-activated potassium channels, arterial remodeling, inflammation, and neurite outgrowth.
Ishii T; Warabi E; Siow RCM; Mann GE
Free Radic Biol Med; 2013 Dec; 65():102-116. PubMed ID: 23792273
[TBL] [Abstract][Full Text] [Related]
20. Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis.
Haga S; Yimin ; Ozaki M
BMC Gastroenterol; 2017 Jan; 17(1):9. PubMed ID: 28086800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
